NCT03744611 is a NA clinical trial of CE in Osteoarthritis, sponsored by Jaseng Medical Foundation.

Who is sponsoring NCT03744611?

NCT03744611 is sponsored by Jaseng Medical Foundation.

What drugs are being tested in NCT03744611?

Interventions in NCT03744611: CE, Placebo.

What condition does NCT03744611 study?

NCT03744611 studies Osteoarthritis.

Is NCT03744611 still recruiting?

NCT03744611 is currently completed. Last updated 25 July 2022.

Last reviewed 2022-07-25 · How we verify

NCT03744611

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy and Safety of Cortex Eucommiae (CE: Eucommia Ulmoides Oliver Extract) in Subjects With Mild Osteoarthritis

Completed NA Last updated 25 July 2022

What this trial tests

NA trial testing CE in Osteoarthritis in 100 participants. Completed in 5 September 2019.

Timeline

22 October 2018

Primary endpoint
5 September 2019

5 September 2019

Quick facts

Lead sponsor	Jaseng Medical Foundation
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	100
Start date	22 October 2018
Primary completion	5 September 2019
Estimated completion	5 September 2019
Sites	3 locations across South Korea

Drugs / interventions tested

CE
Placebo

Conditions studied

Osteoarthritis — all drugs for Osteoarthritis →

Sponsor

Jaseng Medical Foundation

Who can join

Adults 40 to 75, any sex, with Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this clinical trial is to evaluate the efficacy and safety of Cortex Eucommiae (CE: Eucommia ulmoides Oliver extract) in subjects with mild osteoarthritis (OA).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Phytochemicals Targeting BDNF Signaling for Treating Neurological Disorders.
Singh AA, Katiyar S, Song M. · · 2025 · cited 12× · PMID 40149774 · DOI 10.3390/brainsci15030252
Efficacy and safety of Cortex Eucommiae (Eucommia ulmoides Oliver) extract in subjects with mild osteoarthritis: Study protocol for a 12-week, multicenter, randomized, double-blind, placebo-controlled trial.
Ahn HY, Cho JH, Nam D, Kim EJ, et al · · 2019 · cited 12× · PMID 31852118 · DOI 10.1097/md.0000000000018318

Verify or expand the search:

Other trials of CE

Trials testing the same drug.

NCT05202470 — Effectiveness of Telehealth Program in Patients With Type 2 Diabetes · NA · completed

Other recruiting trials for Osteoarthritis

Currently open trials in the same condition.

NCT07404891 — Clinical Trial on the Efficacy and Safety of ALT001 in Osteoarthritis · NA · recruiting
NCT07118501 — A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System · recruiting
NCT06631638 — EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN)) · NA · recruiting
NCT07198750 — "Bimodal vs Unimodal High-Intensity Pulsed Electromagnetic Field Therapy in Older Adults With Knee Osteoarthritis" · NA · recruiting
NCT07006714 — Preoperative Correction of Vitamin D Deficiency in Total Joint Arthroplasty (TJA) · Phase 4 · active not recruiting

Other Jaseng Medical Foundation trials

Trials by the same sponsor.

NCT07126951 — Pilot Study: Clinical Trial of Ultrasound Guiding Pharmacopuncture Therapy for Acute Low Back Pain · NA · not yet recruiting
NCT07304076 — Clinical Research on the Comparative Effectiveness and Safety of JHG002 Therapy for Chronic Low Back Pain: A Multicenter · NA · recruiting
NCT07187336 — The Efficacy and Safety of Shoulder Motion Style Acupuncture Treatment (MSAT) on in Patients With Shoulder Pain Caused b · NA · recruiting
NCT07058376 — Clinical Research of Effectiveness and Safety of Herbal Medicine Strategy for Chronic Low Back Pain · NA · enrolling by invitation
NCT06931951 — The Effectiveness and Safety of Pharmacopuncture on Inpatients With Acute Knee Pain Caused by Traffic Accidents · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03744611 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jaseng Medical Foundation
Last refreshed: 25 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03744611.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing